Helix BioPharma Announces the Appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its Board of Directors
Helix BioPharma Corp. announced the appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its board of directors. Professor Roszkowski-Sliz is replacing Professor Slawomir Majewski, who has stepped down from the board to assume the advisory role of European medical director for Helix.
Professor Roszkowski-Sliz is an expert in the field of lung disease and lung cancers, and is a director at the National Tuberculosis and Lung Diseases Research Institute inWarsawwhere he is also head of the clinical department. In addition, Professor Roszkowski-Sliz consults on lung diseases issues for the Polish Ministry of Health. He received his M.D. from the Medical Academy inWarsawand his Ph.D. from the Postgraduate Medical Center inWarsaw. He is an accomplished researcher with over 230 published papers.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.